Hydrochloric Acid

Hydrochloric Acid

SCHEMBL52012

Cl.N=C(N)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62149 0.94
SCHEMBL27718169 0.89
Hydrochloric Acid SCHEMBL5351148 0.84
Fluoride SCHEMBL28955122 0.84
Guanidine SCHEMBL9794411 0.82
Guanidine SCHEMBL8024162 0.76
Guanidine SCHEMBL17184362 0.76 NOS2 (0.39)
Guanidine SCHEMBL2453389 0.76
Guanidine SCHEMBL3349156 0.76
Guanidine SCHEMBL5053878 0.76 NOS2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004697-A Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material 同济大学 2025-05-16 CN claimed
CN-119546147-A Method for regulating and controlling crystal face growth in perovskite crystallization process and application of method in preparation of solar cell 山东大学 2025-02-28 CN claimed
CN-117979796-A Perovskite layer, preparation method of perovskite layer, perovskite silicon laminated solar cell and photovoltaic module 通威太阳能(成都)有限公司 2024-05-03 CN claimed
CN-117358321-B Chromatography medium and preparation method thereof 赛普(杭州)过滤科技有限公司 2024-03-19 CN claimed
CN-114555565-B Nitrogen-containing heterocyclic compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-03-05 CN claimed
CN-117358321-A Chromatography medium and preparation method thereof 赛普(杭州)过滤科技有限公司 2024-01-09 CN claimed
WO-2021114691-A1 NITROGEN-CONTAINING RING-FUSED COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2021-06-17 WO claimed
CN-110627729-B 2-amino-6-chloropurine, and synthesis method, intermediate and application thereof 南京红杉生物科技有限公司 2021-04-20 CN claimed
EP-3621952-A1 METHOD FOR THE PRODUCTION OF PHENYLGUANIDINES OR THE SALTS THEREOF AlzChem Trostberg GmbH (DE) 2020-03-18 EP claimed
CN-110627729-A 2-amino-6-chloropurine, and synthesis method, intermediate and application thereof 南京红杉生物科技有限公司 2019-12-31 CN claimed
EP-0412358-B1 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES BAYER AG (DE) 1993-09-29 EP claimed
WO-1993013079-A1 ANTIFOLATE QUINAZOLINES AGOURON PHARMACEUTICALS, INC. (US) 1993-07-08 WO claimed
EP-0253396-B1 PROCESS FOR PREPARING 5,6-SUBSTITUTED-2,4-QUINAZOLINEDIAMINES AND INTERMEDIATES WARNER-LAMBERT COMPANY (US) 1993-03-17 EP claimed
EP-0399285-B1 PROCESS FOR THE PREPARATION OF 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES BAYER AG (DE) 1992-09-30 EP claimed
US-5051517-A Reacting a chloroformidine hydrochloride with an oxamohydrazide, forming bonds between carbon and nitrogen and cyclization BAYER AKTIENGESELLSCHAFT (DE) 1991-09-24 US claimed
EP-0412358-A1 3-Amino-5-aminocarbonyl-1,2,4-triazole derivatives BAYER AG (DE) 1991-02-13 EP claimed
EP-0399285-A1 Process for the preparation of 3-amino-5-aminocarbonyl-1,2,4-triazole derivatives BAYER AG (DE) 1990-11-28 EP claimed
EP-0213976-B1 PROCESS FOR PREPARING CARBOXYLIC-ACID CHLORIDES BY PHOSGENATION OF CARBOXYLIC ACIDS, AND CATALYSTS FOR THIS PROCESS SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1990-08-22 EP claimed
EP-0253396-A2 Process for preparing 5,6-substituted-2,4-quinazolinediamines and intermediates WARNER-LAMBERT COMPANY (US) 1988-01-20 EP claimed
EP-0094038-B1 3-AMINO-6-ARYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINES, THEIR PREPARATION AND USE HOECHST AKTIENGESELLSCHAFT (DE) 1987-01-07 EP claimed